Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by fdeslogeson Dec 12, 2015 8:37am
341 Views
Post# 24379134

RE:RE:RE:Big three

RE:RE:RE:Big threeHahaha! :-D Guess I'll have to update my C.V.  ;-)

I stay silent  because I'm as guessing as anybody here. And everybody already said that it probably would come with a deal and upfront or otherwise they wouldn't call for a CC. What else could be said ?

Except maybe : Lord are they good at creating a buzz these bast4rds! :-D

And it's been a while we haven't heard about NASH and Heart fibrosis. (But these are not orphan, by far.)

Besides, I'm just slightly  pissed off because I had spent all week writing this thorough qualitiative valuation / takeover avoidance analysis, to complement my quantitative one, that I was about to post here at the close of the market on friday. And now I guess I'll have to rewrite at least part of it. :-)

You know you're a VERY happy shareholder when that's the only bad thing you have to say about it all. :-D

Enjoy the excitment! It comes free as a part of the "PLI shareholding experience"...
:-)
FD


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse